SEASPINE HOLDINGS CORP (SPNE) Stock Fundamental Analysis
NASDAQ:SPNE - Nasdaq - US81255T1088 - Common Stock - Currency: USD
We assign a fundamental rating of 2 out of 10 to SPNE. SPNE was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of SPNE have multiple concerns. While showing a medium growth rate, SPNE is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
SPNE had negative earnings in the past year.
SPNE had a negative operating cash flow in the past year.
1.2 Ratios
The profitability ratios for SPNE are negative, so there is not much use analyzing them.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SPNE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SPNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SPNE has more shares outstanding
There is no outstanding debt for SPNE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
SPNE has an Altman-Z score of 1.40. This is a bad value and indicates that SPNE is not financially healthy and even has some risk of bankruptcy.
SPNE has a Altman-Z score of 1.40. This is comparable to the rest of the industry: SPNE outperforms 49.08% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that SPNE is not too dependend on debt financing.
SPNE has a Debt to Equity ratio (0.09) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.4 |
ROIC/WACCN/A
WACC8.68%
2.3 Liquidity
SPNE has a Current Ratio of 3.18. This indicates that SPNE is financially healthy and has no problem in meeting its short term obligations.
SPNE's Current ratio of 3.18 is in line compared to the rest of the industry. SPNE outperforms 44.95% of its industry peers.
A Quick Ratio of 1.65 indicates that SPNE should not have too much problems paying its short term obligations.
SPNE's Quick ratio of 1.65 is on the low side compared to the rest of the industry. SPNE is outperformed by 67.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.18 | ||
| Quick Ratio | 1.65 |
3. Growth
3.1 Past
The earnings per share for SPNE have decreased strongly by -20.41% in the last year.
The Revenue has grown by 26.03% in the past year. This is a very strong growth!
The Revenue has been growing by 8.23% on average over the past years. This is quite good.
EPS 1Y (TTM)-20.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
Revenue 1Y (TTM)26.03%
Revenue growth 3Y10.11%
Revenue growth 5Y8.23%
Sales Q2Q%44.57%
3.2 Future
SPNE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.06% yearly.
Based on estimates for the next years, SPNE will show a quite strong growth in Revenue. The Revenue will grow by 11.60% on average per year.
EPS Next Y-1.82%
EPS Next 2Y8.56%
EPS Next 3Y11.83%
EPS Next 5Y2.06%
Revenue Next Year24.57%
Revenue Next 2Y17.4%
Revenue Next 3Y16.89%
Revenue Next 5Y11.6%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SPNE. In the last year negative earnings were reported.
Also next year SPNE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.56%
EPS Next 3Y11.83%
5. Dividend
5.1 Amount
No dividends for SPNE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
9.54
+0.73 (+8.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.42%
Ins Owner Change0%
Market Cap354.91M
Analysts85.71
Price Target16.13 (69.08%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.48%
Min EPS beat(2)-35%
Max EPS beat(2)-5.95%
EPS beat(4)0
Avg EPS beat(4)-27.95%
Min EPS beat(4)-47.45%
Max EPS beat(4)-5.95%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.92%
Min Revenue beat(2)0.23%
Max Revenue beat(2)1.61%
Revenue beat(4)3
Avg Revenue beat(4)0.68%
Min Revenue beat(4)-0.65%
Max Revenue beat(4)1.61%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.54 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.29 | ||
| P/tB | 2.31 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.77
EYN/A
EPS(NY)-1.33
Fwd EYN/A
FCF(TTM)-2.16
FCFYN/A
OCF(TTM)-1.22
OCFYN/A
SpS6.18
BVpS7.38
TBVpS4.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 212.78% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.18 | ||
| Quick Ratio | 1.65 | ||
| Altman-Z | 1.4 |
F-Score3
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)159.81%
Cap/Depr(5y)125.57%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
EPS Next Y-1.82%
EPS Next 2Y8.56%
EPS Next 3Y11.83%
EPS Next 5Y2.06%
Revenue 1Y (TTM)26.03%
Revenue growth 3Y10.11%
Revenue growth 5Y8.23%
Sales Q2Q%44.57%
Revenue Next Year24.57%
Revenue Next 2Y17.4%
Revenue Next 3Y16.89%
Revenue Next 5Y11.6%
EBIT growth 1Y-27.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.08%
EBIT Next 3Y25.82%
EBIT Next 5Y14.6%
FCF growth 1Y-150.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-136.29%
OCF growth 3YN/A
OCF growth 5YN/A